Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCANN Silver DM
- Development stage
- Preclinical
- Lead developer
- Bazelet Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Sublingual
01
Overview
**BCANN Silver DM** is a Bazelet medical cannabis oil product line developed for people living with **Alzheimer's disease and other dementias**. It comprises hybrid, terpene-enriched cannabis oil formulations in medium-chain triglyceride carrier oil, including T1/C28 and T3/C18 presentations. These presentations are low in tetrahydrocannabinol and high in cannabidiol; the T1/C28 formulation is characterized as approximately 1% THC and 28% CBD, while T3/C18 is characterized as approximately 3% THC and 18% CBD. Bazelet describes the BCANN Silver DM series as intended to address behavioral and emotional challenges associated with dementia. ([bazelet-pharma.co.il](https://www.bazelet-pharma.co.il/series/bcann-silver/))
- Brand names
- BCANN Silver DMBCANN Silver DM T1/C28BCANN Silver DM T3/C18
Beyond the preview
Go deeper on BCANN Silver DM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCANN Silver DM.